Comparative effects of diet and simvastatin on markers of thrombogenicity in patients with coronary artery disease

Am J Cardiol. 2003 May 15;91(10):1231-4. doi: 10.1016/s0002-9149(03)00270-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Antineoplastic Agents / analysis
  • Apolipoproteins / blood
  • Apolipoproteins / drug effects
  • Biomarkers / blood
  • C-Reactive Protein / analysis
  • C-Reactive Protein / drug effects
  • Coronary Disease / blood
  • Coronary Disease / diet therapy*
  • Coronary Disease / drug therapy*
  • Female
  • Fibrinogen / analysis
  • Fibrinogen / drug effects
  • Hemostatics / analysis
  • Humans
  • Hyperlipidemias / blood
  • Hyperlipidemias / diet therapy
  • Hyperlipidemias / drug therapy
  • Lipoproteins / blood
  • Lipoproteins / drug effects
  • Male
  • Matrix Metalloproteinase 9 / blood
  • Matrix Metalloproteinase 9 / drug effects
  • Middle Aged
  • Placebo Effect
  • Protease Inhibitors / blood
  • Simvastatin / therapeutic use*
  • Thromboplastin / analysis
  • Thromboplastin / drug effects
  • Thrombosis / blood
  • Thrombosis / prevention & control*
  • Tissue Inhibitor of Metalloproteinase-1 / blood
  • Tissue Inhibitor of Metalloproteinase-1 / drug effects
  • Tumor Necrosis Factor-alpha / analysis
  • Tumor Necrosis Factor-alpha / drug effects

Substances

  • Anticholesteremic Agents
  • Antineoplastic Agents
  • Apolipoproteins
  • Biomarkers
  • Hemostatics
  • Lipoproteins
  • Protease Inhibitors
  • Tissue Inhibitor of Metalloproteinase-1
  • Tumor Necrosis Factor-alpha
  • lipoprotein-associated coagulation inhibitor
  • Fibrinogen
  • C-Reactive Protein
  • Thromboplastin
  • Simvastatin
  • Matrix Metalloproteinase 9